TickerFacts.

Corcept Therapeutics Inc (CORT): Shares Outstanding

Annual figures by period end, from SEC filings.

105.97M
As of 2025-12-31
-0.6%
3-year compound annual growth
-1.9%
5-year compound annual growth
-0.3%
10-year compound annual growth
116.73M2010-12-31: 72.40M2011-12-31: 84.23M2012-12-31: 99.81M2013-12-31: 99.85M2014-12-31: 101.39M2015-12-31: 109.64M2016-12-31: 112.71M2017-12-31: 114.72M2018-12-31: 115.03M2019-12-31: 114.55M2020-12-31: 116.73M2021-12-31: 105.94M2022-12-31: 107.83M2023-12-31: 103.41M2024-12-31: 105.11M2025-12-31: 105.97M105.97M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31105.97M+0.8%2026-02-24, Balance as of period end
2024-12-31105.11M+1.7%2026-02-24, Balance as of period end
2023-12-31103.41M-4.1%2025-02-26, Balance as of period end
2022-12-31107.83M+1.8%2024-02-15, Balance as of period end
2021-12-31105.94M-9.2%2023-02-28, Balance as of period end
2020-12-31116.73M+1.9%2022-02-15, Balance as of period end
2019-12-31114.55M-0.4%2021-02-23, Balance as of period end
2018-12-31115.03M+0.3%2020-02-24, Balance as of period end
2017-12-31114.72M+1.8%2019-02-26, Balance as of period end
2016-12-31112.71M+2.8%2018-02-28, Balance as of period end
2015-12-31109.64M+8.1%2017-03-06, Balance as of period end
2014-12-31101.39M+1.5%2016-03-10, Balance as of period end
2013-12-3199.85M0.0%2015-03-13, Balance as of period end
2012-12-3199.81M+18.5%2014-03-14, Balance as of period end
2011-12-3184.23M+16.3%2013-03-15, Balance as of period end
2010-12-3172.40Mn/a2012-03-13, Balance as of period end